| |
|
|
|
Cytosorbents Cor  
|
|
8.67 -0.04 (-0%) |
08-13 16:00 |
|
Open: |
8.67 |
Pre close: |
8.71 |
Target:
|
12.30 
|
|
High: |
8.78 |
Low: |
8.575 |
Resistance:
|
10.53
11.74
|
|
Volume: |
506,771 |
Market Cap: |
374M |
Support:
|
8.57
7.13
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.13
|
MACD |
MACD(12,26):
|
-0.25 |
|
MA(20): |
9.70 |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
9.22  |
Stochastic Oscillator |
%K(14,3):
|
5.50 |
|
MA(250): |
6.50 |
%D(3): |
6.60 |
|
Average Volume(K) |
3-Month: |
60196
|
52-Week |
High:
|
11.74 |
|
10-Days: |
57530 |
Low: |
3.49 |
|
RSI |
RSI(14):
|
34.09 |
Change(%): |
80.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.540 |
Return on Equity (ttm) |
-98.2 |
Shares Out. (M) |
36.92 |
|
EPS Est. Current Year |
-0.270 |
Return on Assets (ttm) |
-28.5 |
Shares Float (M) |
32.64 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.27 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
67.7 |
% Held by Institutions |
26.73 |
|
Forward EPS |
-0.600 |
Gross Profit (p.s.) |
0.476 |
Shares Short (K) |
3050 |
|
Book Value (p.s.) |
0.590 |
EBITDA (p.s.) |
-0.448 |
P/E |
-16.06 |
|
Sales Per Share |
0.771 |
Qtrly Earnings Growth |
0.00 |
P/BV |
14.69 |
|
Profit Margin |
-62.65 |
Operating Cash Flow
(M) |
-15.73 |
P/S |
11.24 |
|
Operating Margin |
-60.31 |
Levered Free Cash Flow
(M) |
-13.62 |
P/CF |
-20.35 |
|
|
|
|
|
|
